Nothing Special   »   [go: up one dir, main page]

Tinberg et al., 2013 - Google Patents

Computational design of ligand-binding proteins with high affinity and selectivity

Tinberg et al., 2013

View HTML
Document ID
3212801219026024860
Author
Tinberg C
Khare S
Dou J
Doyle L
Nelson J
Schena A
Jankowski W
Kalodimos C
Johnsson K
Stoddard B
Baker D
Publication year
Publication venue
Nature

External Links

Snippet

The ability to design proteins with high affinity and selectivity for any given small molecule is a rigorous test of our understanding of the physiochemical principles that govern molecular recognition. Attempts to rationally design ligand-binding proteins have met with little …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Tinberg et al. Computational design of ligand-binding proteins with high affinity and selectivity
Bennett et al. Improving de novo protein binder design with deep learning
Hie et al. Efficient evolution of human antibodies from general protein language models
Chen et al. A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
Huang et al. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4
Wilkens et al. Solution structure of the ε subunit of the F1-ATPase from Escherichia coli and interactions of this subunit with β subunits in the complex
McShan et al. TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap
Zhu et al. Protein interaction discovery using parallel analysis of translated ORFs (PLATO)
Hsu et al. Entropy calculation of HIV-1 Env gp120, its receptor CD4, and their complex: an analysis of configurational entropy changes upon complexation
Xu et al. Internally deleted human tRNA synthetase suggests evolutionary pressure for repurposing
Gray et al. Unravelling the molecular basis of high affinity nanobodies against HIV p24: in vitro functional, structural, and in silico insights
Wilkinson et al. High Resolution NMR-based Model for the Structure of a scFv-IL-1β Complex
Harris et al. An engineered switch in T cell receptor specificity leads to an unusual but functional binding geometry
Jha et al. An improved Protein G with higher affinity for human/rabbit IgG Fc domains exploiting a computationally designed polar network
Madan et al. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody
Heyne et al. Generating quantitative binding landscapes through fractional binding selections combined with deep sequencing and data normalization
Vlach et al. D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein
Tit-Oon et al. Prediction of the binding interface between monoclonal antibody m102. 4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking
Bijak et al. The current role and evolution of X-ray crystallography in drug discovery and development
Rusnati et al. Recent strategic advances in CFTR drug discovery: an overview
Krueger et al. Atomistic ensemble modeling and small-angle neutron scattering of intrinsically disordered protein complexes: applied to minichromosome maintenance protein
Schlimgen et al. Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies
van Ingen et al. Extension of the binding motif of the Sin3 interacting domain of the Mad family proteins
Hardebeck et al. A FRET-based assay for the identification of PCNA inhibitors
Tam et al. Targeting Ras-binding domain of ELMO1 by computational nanobody design